The China Food and Drug Administration has noted a number of reforms to biopharmaceutical and...
IMS Health and CPHI China provide a market overview and forecasts for 2016-2020.
The Chinese pharmaceutical market is forecast to grow at a compound annual growth rate (CAGR) of 6.9% (+2.5%) between 2015 and 2020, reaching RMB1,003.9 billion by 2020.
Economic growth is forecast to slow to 6.5% in 2016, from 6.9% in 2015, as private consumption growth decelerates. Over the medium term, real gross domestic product (GDP) growth will slow steadily, averaging 5.4% during 2017-2020, driven by a slowdown in investment, while private consumption should hold up better and government consumption will expand rapidly.
Download this free whitepaper to find out more market overviews and forecasts, including in the areas of healthcare provision, prescribing and dispensing, pricing, regulatory environment, and the pharmaceutical business environment.